RecruitingNCT06856343

REBECCA Real-world Early BrEast CanCer mAnagement

REBECCA Real-world Early BrEast CanCer mAnagement REBECCA. a French National Multicentric Real-world Study of Early Breast Cancer Patients

Sponsor

AstraZeneca

Enrollment

126 participants

Start Date

Dec 30, 2024

Study Type

OBSERVATIONAL

Conditions

Breast Cancer

Summary

This is a French observational, national, multicenter prospective cohort study of patients with HER2-negative eBC treated with olaparib at their physician's discretion.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This real-world study is collecting data on how patients with early-stage HER2-negative breast cancer are managed in everyday clinical practice after starting adjuvant olaparib — a targeted therapy that helps prevent cancer recurrence in certain high-risk patients. **You may be eligible if...** - You are 18 years or older (male or female) - You have been diagnosed with HER2-negative early breast cancer - Your doctor has decided to start you on adjuvant olaparib treatment - You do not object to your data being used in this study **You may NOT be eligible if...** - You do not consent to participate - You were enrolled in the Early Access Program for olaparib Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(58)

Research Site

Clermont-Ferrand, Auvergne-Rh ne-Alpes, France

Research Site

Gleizé, Auvergne-Rh ne-Alpes, France

Research Site

Grenoble, Auvergne-Rh ne-Alpes, France

Research Site

Lyon, Auvergne-Rh ne-Alpes, France

Research Site

Metz-Tessy, Auvergne-Rh ne-Alpes, France

Research Site

Saint-Etienne, Auvergne-Rh ne-Alpes, France

Research Site

Saint-Priest-en-Jarez, Auvergne-Rh ne-Alpes, France

Research Site

Thonon-les-Bains, Auvergne-Rh ne-Alpes, France

Research Site

Valence, Auvergne-Rh ne-Alpes, France

Research Site

Valence, Auvergne-Rh ne-Alpes, France

Research Site

Dijon, Bourgogne-Franche-Comt, France

Research Site

Plérin, Brittany Region, France

Research Site

Rennes, Brittany Region, France

Research Site

Saint-Brieuc, Brittany Region, France

Research Site

Saint-Grégoire, Brittany Region, France

Research Site

Chambray-lès-Tours, Centre-Val de Loire, France

Research Site

Saint-Doulchard, Centre-Val de Loire, France

Research Site

Bezannes, Grand Est, France

Research Site

Haguenau, Grand Est, France

Research Site

Nancy, Grand Est, France

Research Site

Beauvais, Hauts-de-France, France

Research Site

Beuvry, Hauts-de-France, France

Research Site

Compiègne, Hauts-de-France, France

Research Site

Creil, Hauts-de-France, France

Research Site

Dechy, Hauts-de-France, France

Research Site

Lille, Hauts-de-France, France

Research Site

Lille, Hauts-de-France, France

Research Site

Saint-Martin-Boulogne, Hauts-de-France, France

Research Site

Salouël, Hauts-de-France, France

Research Site

Saint-Pierre-des-Corps, La R Union, France

Research Site

FORT de France Cedex, Martinique, France

Research Site

Agen, New Aquitaine, France

Research Site

Libourne, New Aquitaine, France

Research Site

Limoges, New Aquitaine, France

Research Site

Périgueux, New Aquitaine, France

Research Site

Poitiers, New Aquitaine, France

Research Site

Caen, Normandy, France

Research Site

Rouen, Normandy, France

Research Site

Béziers, Occitanie, France

Research Site

Montpellier, Occitanie, France

Research Site

Montpellier, Occitanie, France

Research Site

Nîmes, Occitanie, France

Research Site

Perpignan, Occitanie, France

Research Site

Toulouse, Occitanie, France

Research Site

Nantes, Pays de la Loire Region, France

Research Site

Avignon, Provence-Alpes-C Te d'Azur, France

Research Site

Fréjus, Provence-Alpes-C Te d'Azur, France

Research Site

Marseille, Provence-Alpes-C Te d'Azur, France

Research Site

Nice, Provence-Alpes-C Te d'Azur, France

Research Site

Argenteuil, Île-de-France Region, France

Research Site

Champigny-sur-Marne, Île-de-France Region, France

Research Site

Le Blanc-Mesnil, Île-de-France Region, France

Research Site

Osny, Île-de-France Region, France

Research Site

Paris, Île-de-France Region, France

Research Site

Paris, Île-de-France Region, France

Research Site

Paris, Île-de-France Region, France

Research Site

Paris, Île-de-France Region, France

Research Site

Sarcelles, Île-de-France Region, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06856343

Related Trials

Genomic Services Research Program

NCT025959571 location

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT070671381 location

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

NCT06103864316 locations

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

NCT068852031 location

Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

NCT070707652 locations